These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 18854563)

  • 1. New insights into the pathogenesis of serous ovarian cancer and its clinical impact.
    Levanon K; Crum C; Drapkin R
    J Clin Oncol; 2008 Nov; 26(32):5284-93. PubMed ID: 18854563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
    Vang R; Shih IeM; Kurman RJ
    Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaplastic papillary tumor of the salpinx: report of a case using microsatellite analysis.
    D'Adda T; Pizzi S; Bottarelli L; Azzoni C; Manni S; Giordano G
    Int J Gynecol Pathol; 2011 Nov; 30(6):532-5. PubMed ID: 21979587
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
    Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
    Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
    Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R
    Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
    Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
    Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
    Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis.
    Li J; Fadare O; Xiang L; Kong B; Zheng W
    J Hematol Oncol; 2012 Mar; 5():8. PubMed ID: 22405464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursors to pelvic serous carcinoma and their clinical implications.
    Folkins AK; Jarboe EA; Roh MH; Crum CP
    Gynecol Oncol; 2009 Jun; 113(3):391-6. PubMed ID: 19237187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer.
    Nishida N; Murakami F; Higaki K
    Pathol Int; 2016 Jun; 66(6):337-42. PubMed ID: 27250113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
    Guo DH; Pang SJ; Shen Y; Li Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.
    Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A
    Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.